A chemical probe toolbox for dissecting the cancer epigenome
- PMID: 28228643
- DOI: 10.1038/nrc.2016.148
A chemical probe toolbox for dissecting the cancer epigenome
Erratum in
-
A chemical probe toolbox for dissecting the cancer epigenome.Nat Rev Cancer. 2017 Mar 23;17(4):268. doi: 10.1038/nrc.2017.26. Nat Rev Cancer. 2017. PMID: 28332503 No abstract available.
Abstract
Cancer cell hallmarks are underpinned by transcriptional programmes operating in the context of a dynamic and complicit epigenomic environment. Somatic alterations of chromatin modifiers are among the most prevalent cancer perturbations. There is a pressing need for targeted chemical probes to dissect these complex, interconnected gene regulatory circuits. Validated chemical probes empower mechanistic research while providing the pharmacological proof of concept that is required to translate drug-like derivatives into therapy for cancer patients. In this Review, we describe chemical probe development for epigenomic effector proteins that are linked to cancer pathogenesis. By annotating these reagents, we aim to share our perspectives on an informative 'epigenomic toolbox' of broad utility to the research community.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
